MORECare research methods guidance development:Recommendations for ethical issues in palliative and end-of-life care research by Gysels, Marjolein et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1177/0269216313488018
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Gysels, M., Evans, C. J., Lewis, P., Speck, P., Benalia, H., Preston, N. J., ... Higginson, I. J. (2013). MORECare
research methods guidance development: Recommendations for ethical issues in palliative and end-of-life care
research. Palliative Medicine, 27(10), 908-917. DOI: 10.1177/0269216313488018
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 15. Dec. 2017
Palliative Medicine
27(10) 908 –917
© The Author(s) 2013
Reprints and permissions:  
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0269216313488018
pmj.sagepub.com
P ALLIATIVE
MEDICINE
MORECare research methods 
guidance development: 
Recommendations for ethical issues in 
palliative and end-of-life care research
Marjolein Gysels Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s 
College London, London, UK and Centre for Social Science and Global Health, University of Amsterdam, Amsterdam, The 
Netherlands
Catherine J Evans Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s 
College London, London, UK
Penney Lewis Centre for Medical Law and Ethics, Dickson Poon School of Law, King’s College London, 
London, UK
Peter Speck Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s College 
London, London, UK
Hamid Benalia Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s 
College London, London, UK
Nancy J Preston School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK 
and International Observatory on End of Life Care, Faculty of Health and Medicine, Lancaster University, UK
Gunn E Grande School of Nursing, Midwifery and Social Work, The University of Manchester, 
Manchester, UK
Vicky Short School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
Eleanor Owen-Jones School of Nursing, Midwifery and Social Work, The University of Manchester, 
Manchester, UK
Chris J Todd School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
Irene J Higginson Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s 
College London, London, UK.
Abstract
Background: There is little guidance on the particular ethical concerns that research raises with a palliative care population.
Aim: To present the process and outcomes of a workshop and consensus exercise on agreed best practice to accommodate ethical 
issues in research on palliative care.
Design: Consultation workshop using the MORECare Transparent Expert Consultation approach. Prior to workshops, participants 
were sent overviews of ethical issues in palliative care. Following the workshop, nominal group techniques were used to produce 
candidate recommendations. These were rated online by participating experts. Descriptive statistics were used to analyse agreement 
and consensus. Narrative comments were collated.
Setting/participants: Experts in ethical issues and palliative care research were invited to the Cicely Saunders Institute in London. 
They included senior researchers, service providers, commissioners, researchers, members of ethics committees and policy makers.
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Results: The workshop comprised 28 participants. A total of 16 recommendations were developed. There was high agreement on the 
issue of research participation and high to moderate agreement on applications to research ethics committees. The recommendations 
on obtaining and maintaining consent from patients and families were the most contentious. Nine recommendations were refined on 
the basis of the comments from the online consultation.
Conclusions: The culture surrounding palliative care research needs to change by fostering collaborative approaches between all 
those involved in the research process. Changes to the legal framework governing the research process are required to enhance the 
ethical conduct of research in palliative care. The recommendations are relevant to all areas of research involving vulnerable adults.
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Introduction
There is limited research investment in the development 
and evaluation of interventions in palliative care.1,2 
Research is required to develop quality palliative care.3–7 
This will provide evidence to address deficits in care, to 
establish whether unproven therapy helps patients and to 
ensure that palliative care can secure the resources 
required.4
Research in palliative care raises particular ethical 
concerns,6 which have generated intense debate with 
little consensus of views.8,9 The ethical decisions 
regarding the design and conduct of research determine 
the nature and quality of the research undertaken. 
Whether patients at the end of their lives should be 
invited to participate in research is a key issue widely 
discussed in the literature.10 On this issue hinges the 
moral justification of research in palliative care.11 
These views further impact research ethics committees 
(RECs), which are known as Institutional Review 
Boards (IRBs) in the United States,12–14 whose judg-
ments determine the quality and safety of interventions 
detailed in researchers’ ethics applications.12 Informed 
consent is challenging in palliative care research as one 
has to work in circumstances where time is restricted, 
and patients experience fluctuating/declining physical 
and mental capacity.15 In addition, the concerns of fam-
ily members require consideration as their views are 
likely to influence patient participation.16 Given the 
divergent ideas about the ethical conduct of palliative 
care research and the lack of empirical evidence, there 
is a need to identify and arrive at best practices in this 
field.
The MORECare project aims to identify, appraise 
and synthesise ‘best practice’ methods to develop and 
evaluate palliative care, particularly focusing on com-
plex service-delivery interventions and reconfigura-
tions.17 A main intended output is Methods Guidance on 
Developing and Evaluating Palliative Care (http://www.
csi.kcl.ac.uk/morecare.html). This guidance is under-
pinned by systematic reviews of the evidence10,18 and, in 
areas of contentious evidence, expert consensus on best 
methodological practice. A series of expert ‘think tank’ 
workshops were held to generate recommendations and 
build consensus on best practice on identified gaps in 
the evidence base and issues of particular significance. 
We held such a workshop in the summer of 2011 regard-
ing ethical issues in research in this area. This article 
aims to present the process and outcomes of the work-
shop and consensus exercise on agreed best practice to 
accommodate ethical issues in research on palliative 
care.
Methods
The workshop
Design. A one-day closed workshop with invited 
experts, who were identified through the published litera-
tures on ethical issues in palliative care, the networks of 
the members of the Project Advisory Group, and searches 
on the Internet. The participants included senior research-
ers (epidemiologists, ethicists, social scientists and law-
yers), service providers (palliative care consultants and 
allied health professionals in palliative care), commis-
sioners (from hospital trusts and hospices), members of 
RECs or research governance bodies, and policy makers 
(national organisations in palliative care). They all had 
expertise in palliative care and the ethical issues involv-
ing research in this area, and they came from different 
parts of the United Kingdom. The workshop aimed to 
debate the ethical challenges of undertaking research in 
palliative care and to generate recommendations on best 
ethical practices. A systematic literature review on par-
ticipation in palliative care informed the design of the 
workshop.10
Content. The workshop focused on three topics that 
were identified as particularly challenging in palliative 
care research: research participation, informed consent, 
and applications to RECs. These topics were derived and 
informed by the systematic review, which was under-
taken in preparation of the workshop. Their suitability 
for the focus of the workshop was discussed in a meeting 
with the Project Advisory Group. Participants were 
asked to consider specific questions on these areas (see 
Box 1).
910 Palliative Medicine 27(10)
Box 1. Questions discussed in the work groups of the 
workshop.
Research participation
•	 What is best practice to enable patients to partici-
pate in research on palliative and end-of-life care 
(P&EoLC) and protect them from harm?
•	 How can we capture the willingness of individu-
als to participate in research on P&EoLC, and 
how can we balance the interests of families with 
those of the patient?
Applications to RECs
•	 How can we overcome the challenges in relation 
to REC members’ review processes and evalua-
tions of EoLC research?
Informed consent
•	 What is best practice in obtaining and maintain-
ing consent for patients and family caregivers 
who participate in EoLC research?
•	 How can we enable individuals with fluctuating 
or declining capacity (or those who lack capacity) 
to participate in research on P&EoLC?
•	 How should we balance the need to give potential 
participants time to consider participation with 
the particular time constraints of research at the 
end of life associated with nearness to death?
Format. Three presentations were held to provide an over-
view of the state of the science of these three topics of the 
workshop, and this was followed by discussion. Partici-
pants were divided according to their expertise and interest 
into three work groups that focused on one of the three top-
ics. We used nominal group techniques19 to structure the 
process of generating recommendations and forming a con-
sensus on their priority ordering. The work groups dis-
cussed the questions asked and then individually wrote 
down recommendations. The participants then shared in 
turn their recommendations presenting the most important 
first, and their rationales. Recommendations were recorded 
Figure 1. The classification of recommendations.
on a flip chart and discussed by the group combining dupli-
cates. The recommendations written down individually 
were scanned, and together with the recommendations 
combined in groups, were sent to the MORECare team 
members undertaking the analysis. All discussions were 
audio-recorded and transcribed. We used all data gathered 
in the workshop for the analysis.
Online consultation
Following the workshop, all the recommendations were 
entered into an Excel spreadsheet. We then combined 
duplicates, identified those specific to palliative care 
research and checked the wording for clarity. Doubts were 
resolved by discussion among the team members. A set of 
recommendations was agreed on among the project 
researchers and posted as an online survey to participants 
in the workshop and members of the MORECare Project 
Advisory Group comprising senior representatives from 
academia, service providers, commissioners, policy mak-
ers, the voluntary sector and lay members (see 
Acknowledgements).
Participants in the online survey were asked to rate how 
much they agreed with the recommendations on a scale 
from 1–9, where 1 was strongly disagree and 9 strongly 
agree. A space for comments was provided for each recom-
mendation, and there was a general comments section. The 
ratings were analysed using descriptive statistics to permit 
analysis of consensus and rated importance (see Figure 1). 
The comments were read and considered in the light of the 
quantitative results.
Ethics approval
The University of Manchester REC approved the 
MORECare study (ref no. 10328). The online consensus 
recommendations were presented to the chair for approval 
prior to posting.
Results
The workshop comprised 28 participants (ethicists, aca-
demics in palliative care, members of RECs, service 
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providers and commissioners). In all, 25 participants 
took part in the work group discussions: eight in group 
1, seven in group 2 and eight in group 3. Sixteen recom-
mendations were included in the online survey. From 
the 61 people (24 attendees and 37 project advisory 
group members) who were invited to the online consul-
tation, 26 responded.
The workshop
Group 1 discussion: participation in research on palliative 
care. The starting point of the discussion concerned the 
general perception that it is inappropriate to involve people 
with palliative care needs in research and how this hampers 
the development of the evidence base informing palliative 
care. A workshop participant summed up the prevailing 
view regarding research with this population:
The culture within our society and especially health care, is 
that research is extra to treatment, burdensome and unnecessary. 
(participant G106)
These ideas can be challenged by integrating research 
into routine health care. Participants recommended that 
while conducting their studies, researchers can use the 
opportunity to document barriers and facilitators to 
research. This can then provide further evidence of the 
impact of research on researchers and the experiences of 
patients and carers. The evidence generated should be 
inclusive of all research participants who consent to par-
ticipate.
Participants discussed the specific nature of research in 
palliative care and identified the following: the research 
process needs to be sensitive to the changing characteristics 
of the population associated with advancing disease, there 
needs to be attention to the challenges researchers face in 
palliative care research and supervision and support for 
researchers in the field is essential.
Careful consideration of a study is required to accom-
modate the problems associated with research in this field 
(e.g. recruitment, attrition, missing data). Studies need 
sufficient resources, flexible designs and research proce-
dures, preferably with mixed methods. Collaborative 
approaches and participative designs were recommended 
where all the different participants are involved in the 
research process.
Group 2 discussion: seeking REC approval. This group 
shared experiences about the difficulties of obtaining ethi-
cal clearance as one of the greatest challenges of the 
research process in palliative care research. RECs apply 
criteria that are relevant for research in general, but these 
may not be attuned to the specificities of palliative care. 
The Health Research Authority’s standardisation of the 
National Health Service’s ethical review process was 
considered to exacerbate these challenges. Standardisation 
was viewed as directed towards protecting RECs from lia-
bility and as stifling common sense in concrete research 
situations.
As researchers need to operate within established ethical 
frameworks, they should join RECs to inform decisions 
and promote understanding of research on palliative care. A 
way of enhancing discussion at RECs was for researchers 
to ensure greater involvement of project user representa-
tives within the research and application process, for exam-
ple, by attending REC meetings with researchers. This 
could further validate the research proposal, demonstrating 
the involvement of users in the study design and the accept-
ability of the methods proposed to users:
... “RECs [...] are not unusual in being more risk averse in their 
decision making for others than they would be for themselves” 
[...] So they need to be persuaded to balance that ‘natural’ 
paternalism with evidence of how [...] people who are dying 
can be treated as responsible autonomous beings capable of 
taking risks and burdens. (participant G2010)
Participants recommended that mutual education should 
be a priority. RECs require training on conducting pallia-
tive care research, and researchers require greater knowl-
edge about the legal framework within which these 
committees operate. Participants noted that RECs should 
have clear codes, standards and competencies on palliative 
care. Participants agreed that the establishment of a 
Research Ethics Network specifically for palliative care 
could further develop the essential competencies, resources 
(such as manuals, templates for participation information 
sheets) and support for researchers.
Group 3 discussion: informed consent. Consent needs to be 
embedded in a research culture. Participants observed that 
this could be cultivated in care settings by informing 
patients on admission that the facility conducts research. At 
this early stage, ‘consent to consent’ can be sought, which 
is a way of screening people to identify those who are inter-
ested in research and thereby minimise gatekeeping.
Participants agreed that the format of participant infor-
mation sheets can increase the burden of the consent pro-
cess. The level of detail needs to be proportional to the risks 
and burdens involved. Participant information sheet tem-
plates for palliative care could be developed and made 
available from central repositories.
The often fluctuating capacity of the palliative care pop-
ulation presents serious challenges to the consent process. 
The participants proposed advance consent (early informed 
consent when the patient still has capacity) as a solution to 
the problem of fluctuating capacity. Participants recom-
mended that such advance consent should be legally 
effective for all research, rather than limited to Clinical 
Trials of an Investigational Medicinal Product (CTIMPs).20 
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Currently, the Mental Capacity Act 2005 (the relevant leg-
islation in England and Wales governing health and welfare 
decision-making in relation to incompetent adults) does not 
permit research involving incompetent adults on the basis 
of advance consent.21 Instead, necessity and risk/benefit 
criteria are imposed, and assent must be obtained from a 
non-professional carer based on what the patient’s wishes 
and feelings about participation in the project would be 
were the patient competent.22
As a matter of good practice, participants also recom-
mended that if advance consent were to be relied upon for 
all trials, contemporaneous assent from someone who is 
close to the patient and knows whether they would have 
wished to participate in the research project should also be 
obtained, as is currently required for non-CTIMPs under 
the Mental Capacity Act 2005, s. 32.
In the absence of such legal change, participants recom-
mended that when obtaining consent from a competent par-
ticipant for a non-CTIMP study, the researchers should 
anticipate the potential loss of capacity and in addition, fulfil 
the requirements of the Mental Capacity Act21 by obtaining 
assent from someone close to them and by meeting the risk/
benefit criteria in the Mental Capacity Act. This would pro-
vide ‘belt and braces’ (in the words of participant G3018) 
for consent for patients with fluctuating/declining capacity.
Consent should be a continuous process to ensure sensi-
tivity to changes in an individual’s attitude to participation 
and signs of distress, especially when capacity is rapidly 
declining. Further research is necessary on how and when 
to assess capacity.
Limited time characterises research at the end of life 
(EoL), while time is also needed to consider consent. In 
some situations, it is important to allow patients to partici-
pate in studies, without having 24 h to consider their deci-
sion to enrol, which is often required by RECs. These 
circumstances require anticipation and specification in the 
study protocol to avoid coercion.
The online consultation
Table 1 presents the recommendations by subject area. A 
box and whisker plot shows the ratings of the recommenda-
tions in Figure 2.
Research participation. The median scores and narrow 
inter-quartile ranges show strong agreement on four recom-
mendations of research participation. Especially, recom-
mendation 1 received strong agreement and high consensus. 
However, recommendations with wider ranges indicate 
divergence and likely areas of contention. Recommenda-
tion 7 triggered most disagreement and low consensus 
about the combination of clinician–researcher roles.
Applications to RECs. The median scores and range indi-
cate moderate to high agreement on the recommendations 
in the area of making applications to RECs. However, rec-
ommendation 10 triggered only moderate agreement and 
low consensus about the idea of establishing a research eth-
ics network in palliative care. The concern here expressed 
in the narrative comments was that research in palliative 
care could be set apart from other research.
Obtaining and maintaining consent. The recommendations 
on obtaining and maintaining consent from patients and 
families were the most contentious. They had the largest 
divergence in priority ordering. Concerns especially related 
to recommendation 16 about the continuous process of 
informed consent, which entails the risk of making research 
impossible if there would be too many regulatory 
requirements.
Respondents expressed uncertainty regarding recom-
mendation 14 in terms of its feasibility and implications. 
This was due to respondents’ lack of expertise on legal 
issues, which they also admitted with regard to recommen-
dation 15. Here, objections were made to the mechanism of 
assent. In addition to the requirements of this recommenda-
tion, one respondent pointed out that ethical approval 
would need to be obtained from a REC authorised to 
approve projects under the Mental Capacity Act.
Table 2 presents the final recommendations, which were 
refined in light of the narrative comments from the consul-
tation. We did not change all recommendations for the fol-
lowing reasons: when the comments raised questions about 
operationalisation that went beyond the purpose of the rec-
ommendation, if respondents reported a lack of expertise 
about the recommendation or if issues were already cov-
ered by other recommendations.
Discussion
Although the ethical debate on whether patients near the 
EoL should be considered ‘too vulnerable’ to be involved 
in research is far from settled, the participants in this 
workshop started from the idea that research is needed in 
palliative care. They therefore concentrated on best prac-
tices of research participation to foster scholarship in this 
area. Participants recognised that the idea that research 
with this population is not justified underlies the two other 
issues of this workshop. It determines REC members’ atti-
tudes towards palliative care research and the difficulties 
of conducting research in care settings that complicate the 
consent process. A change in culture surrounding pallia-
tive care research was viewed as the most important rec-
ommendation, which can lead to new ways of thinking 
about research and can open up new ways of approaching 
this area. Although the guiding question for this workshop 
focused on the patient, the workshop participants recog-
nised the involvement of all those involved in the research 
process. They were not considered as separate entities, but 
the reality of their interaction was taken into account.
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RECs are often especially cautious to grant ethical 
approval to research applications in palliative care.12 
This relates to societal concerns about involving people 
with life-limiting conditions in burdensome research 
Table 1. List of recommendations with mean and medium scores (n = 26).
Recommendations on topic: research participation Mean Median IQR
 1 To enhance participation in research on palliative and end-of-life care (P&EoLC), closer 
working and open communication between practitioners, researchers and users is required 
to increase awareness and understanding of P&EoLC research.
7.9 8.5 7.75–9
 2 Practitioners, members of research ethics committees (RECs) and researchers need 
adequate training in order to address the practical and ethical challenges associated with 
assessing and conducting research at the EoL.
7.3 8 7–9
 3 Research protocols require flexibility to accommodate the fluctuating symptoms or 
levels of competence often experienced by patients receiving palliative care (e.g. flexible 
recruitment strategies and data collection methods).
7.0 7 6–8.25
 4 Respect is required for autonomous decisions of patients and carers regarding their 
participation in research to avoid limiting their participation through inappropriate 
gatekeeping and paternalistic attitudes.
7.9 9 7–9
 5 To incorporate wide inclusion criteria in studies on P&EoLC, a sensitive approach to 
recruitment is required that demonstrates empathy, is responsive to an individual’s level of 
understanding and emphasises the voluntary nature of participation.
7.6 8 7–9
 6 Further evidence (especially qualitative) is needed on why patients (and practitioners) 
may hold positive or negative attitudes towards participation in research and the reasons 
behind, for example, gatekeeping.
6.8 7 6–8
 7 Greater development of roles that combine clinical and researcher activities is needed in 
order to improve research–practice interface and aid recruitment.
5.6 6 4.75–7
Recommendations on topic: making ethical and governance applications to RECs and Research Governance bodies
 8 Ethical and governance applications are enhanced by collaborative working between 
researchers and lay user representatives throughout the project by jointly developing 
Participant Information Sheets (regarding proportionality and the clarity and acceptability 
of language), developing/reviewing the suitability of data collection tools, a lay summary 
in the ethical application and by accompanying researchers to the REC review on the 
application for P&EoLC research.
7.0 7 6.75–8
 9 RECs require clear codes of conduct, standards and competencies for assessing research in 
P&EoLC.
7.3 8 7–9
10 The establishment of a Research Ethics Network for P&EoLC research could further 
develop methods and guidance on undertaking research at the EoL.
6.5 7 6–8
11 Providing feedback to REC members on participants’ experiences of their involvement in 
P&EoLC research could widen the discussion on the degree patients are burdened, or not, 
by the research process.
7.3 7 7–9
Topic: obtaining and maintaining consent from patients and families
12 To enhance processes of consent requires P&EoLC organisations to create a research-
aware culture for practitioners by informing practitioners and patients on admission to a 
service that the organisation is actively involved in research.
7.0 7 6–9
13 To enhance processes of consent requires P&EoLC organisations to create a research-
aware culture for practitioners by adopting a policy of consent to consent (consent to be 
approached about a research study).
6.3 7 5–8
14 Seek to change the law, so that advance consent is legally effective for all research and not 
limited to Clinical Trials of Investigational Medicinal Products (CTIMPs).
6.3 7 5–8.25
15 When obtaining consent from a competent participant for a non-CTIMP study, anticipate 
the potential loss of capacity and fulfil the requirements of the Mental Capacity Act 2005 
by obtaining assent from a carer and meeting the risk/benefit criteria for non-therapeutic 
projects.
6.8 7 5–8.25
16 A continuous process of consent is required to ensure sensitivity to changes in an 
individual’s attitude, ability to participate and careful monitoring of signs of verbal or non-
verbal distress.
6.5 7.5 5–9
IQR: inter-quartile range.
*The participants were asked how much they agree with each recommendation, where 1 was ‘strongly disagree’ and 9 ‘strongly agree’.
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with limited individual benefit. RECs may be less famil-
iar with the issues that are particular to this field14,23 and 
with research designs required to accommodate complexities 
associated with varying deteriorating illness trajecto-
ries.12,14,23 The involvement of a user representative in 
the process of REC review of the application could 
greatly enhance mutual understanding between REC 
members and those conducting the research (recommen-
dation 8). Submitting decisions made by RECs to exter-
nal peer review could increase accountability and 
transparency on their decision-making processes (rec-
ommendation 10).
The work group on informed consent addressed the 
importance of undertaking the consent process in a way 
that enables individuals with fluctuating/declining capacity 
to participate in research. A way forward is for advance 
consent to be legally effective for all research, rather than 
limited to CTIMPs.20 The recommendation to change the 
law is a first step in the development of standards for 
research on palliative care. Such legal change could pro-
vide an example for other regulatory contexts relating to 
the involvement in research of people who have impaired 
capacity, both in Europe and the United States, where pol-
icy guidance is either lacking or diverging in a mixed legal 
framework.24–26 The wider use of advance consent could 
reduce attrition and missing data, which are common chal-
lenges in palliative care research. A separate recommenda-
tion15 situates this change in the current legal framework 
for medical research by specifying the requirements from 
other legal provisions that are directly related to this new 
measure, such as the Mental Capacity Act, so that it is fully 
operational.
The recommendations were generated in a think-tank 
involving discussion and consensus of expert views on 
undertaking research with individuals requiring palliative 
care and priority rating. The online consultation allowed 
anonymous rating and commentary from a broader group 
of experts. Recommendation 4 concerned the importance 
of patients’ autonomous decision-making to counter 
gatekeeping and paternalism. This recommendation had 
the highest score, showing the priority of allowing and 
enabling individuals to consider participation in research. 
This is consistent with most patients’ experiences of par-
ticipating in research, which can bring direct benefits, 
shown by a systematic review conducted in preparation 
for the think-tank.10
Recommendation 1 on the need to enhance awareness 
and understanding of palliative care research through 
closer working between different parties scored second 
highest and reached greatest consensus. The comment this 
recommendation received of being ‘self-evident’ under-
scores that this is the main target to which one should work 
in this field. The third highest rated recommendation 
shows the importance given to inclusiveness of a popula-
tion (older people, the bereaved, those with fluctuating 
capacity) who are often excluded from designs that gener-
ate high-level evidence according to criteria used in evi-
dence-based medicine,27 but who are of most relevance to 
palliative care.
Recommendation 7 on the development of combined 
clinical and researcher roles received the lowest scores. 
The comments outlined the advantages of working sepa-
rately within clearly defined roles. This recommendation 
does not prescribe complete combined training, but rather 
an understanding of situations when care takes priority, 
and a sense for research opportunity. Within a collabora-
tive model, people with clinical or researcher roles acquire 
insight into the aims and procedures of one another’s 
expertise. Active engagement enhances a sense of owner-
ship of a study, which improves the research–practice 
interface. The narrative comments to recommendation 13 
showed that there was confusion about the term ‘consent 
to consent’ as it suggests an additional layer of bureau-
cracy before the actual consent process. However, it refers 
to a screening process of patients upon admission to a ser-
vice, by which they show their willingness to be approached 
to participate into future studies. In addition, the low score 
of recommendation 14 was due to the commentators’ 
Figure 2. Box and whisker plot of participants’ (n = 26) ratings of the 16 recommendations for the ethical issues in palliative and 
end-of-life care research.
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Table 2. Summary of narrative comments and final refined recommendations.
No. Summary of narrative comments for each draft 
recommendation
Recommendation (changes from draft recommendations in 
italics)
R3 Flexibility was recognised to be important in palliative 
and end-of-life (EoL) care, but respondents qualified it by 
stating that the issues that needed flexibility needed to be 
carefully considered in the protocol, rather than allowing 
ad hoc changes when things do not work as expected.
Research protocols require carefully considered flexibility 
to accommodate the fluctuating symptoms or levels of 
competence often experienced by patients receiving 
palliative care (e.g. flexible recruitment strategies and data 
collection methods).
R5 Although this recommendation was highly rated, some 
comments showed that responders did not consider it 
sufficiently specific to palliative and EoL care. Comments 
show that the link between the wide inclusion criteria and 
the recruitment approach needs clarification.
Wide inclusion criteria in studies on palliative and EoL care 
are needed in order to include those who are more difficult to 
reach (e.g. older people, the bereaved, those with fluctuating 
capacity). Therefore a sensitive approach to recruitment 
is required that demonstrates empathy, is responsive to 
an individual’s level of understanding and emphasises the 
voluntary nature of participation.
R7 This recommendation triggered disagreement about the 
combination of clinician–researcher roles. The advantages 
of working separately were outlined. One comment 
mentioned the need for documenting resistance to 
collaboration between clinicians and researchers.
Greater development of clearly defined roles that combine 
clinical and researcher activities is needed in order to 
improve research–practice interface and aid recruitment.
R8 As research needs to fit with clinical practice, two 
comments mentioned the benefit of having a clinician 
involved. Two comments focused on the need to shorten 
the sentence. One respondent warned to be mindful 
of the burden to lay users. Another one pointed out 
the competencies of the user representative that are 
required to advocate for the interests of users to 
ethics committees. Their power of persuasion towards 
regulatory committees was acknowledged.
Ethical and governance applications are enhanced 
by collaborative working with competent lay user 
representatives throughout the project, by developing 
Participant Information Sheets (regarding proportionality 
and the clarity and acceptability of language), developing/
reviewing the suitability of data collection tools, a lay 
summary in the ethical application and by accompanying 
researchers to the research ethics committee (REC) 
review on the application for EoL care research.
R9 This recommendation raised doubt in most comments 
about the benefit of considering palliative and EoL care 
research as different from other medical research, as 
this implies the danger that patients get categorised as 
‘vulnerable’, which can lead to paternalistic attitudes. One 
comment pointed at the specific and sensitive nature of 
palliative care research for which particular expertise 
needs to be developed. Another comment stated that 
RECs need guidance regarding palliative and EoL care 
in order to overcome their over-protective attitudes 
towards patients.
RECs require clear codes of conduct, standards and 
competencies for assessing and facilitating research in 
palliative and EoL care.
R10 One respondent is not in favour of the idea of establishing 
a research ethics network in palliative and EoL care, again 
because it could shield it off from other areas of research. 
This idea led to two questions on its purpose and 
operationalisation.
The establishment of a Research Ethics Network for 
palliative and end-of-life care (P&EoLC) research could 
further develop methods and guidance on undertaking and 
facilitating research at the EoL.
R12 The value of a research-aware culture was confirmed. 
Information-giving to patients should take account of 
patients’ specific need for information.
To enhance processes of consent requires P&EoLC 
organisations to create a research-aware culture for 
practitioners by sensitively informing practitioners and 
patients on admission to a service that the organisation is 
actively involved in research.
R13 This recommendation provided confusion due to 
respondents’ unfamiliarity with the term ‘consent to 
consent’. One respondent wrote: ‘consent to consent!!’, 
expressing his/her disbelief at the thought of another formal 
requirement in order to be able to approach patients.
To enhance processes of consent requires P&EoLC 
organisations to create a research-aware culture for 
practitioners by adopting a policy of consent to consent (a 
screening procedure to identify people interested in taking part 
in a research study).
R16 Respondents cautioned against the further 
bureaucratisation that this recommendation could imply if 
consent would mean the repetition of the formal written 
consent process and thus make research impossible. 
The need for a sensitive and well-trained researcher is 
emphasised.
A continuous process of consent, in which the original 
written consent does not necessarily needs to be repeated, is 
required to ensure sensitivity to changes in an individual’s 
attitude, ability to participate and careful monitoring of 
signs of verbal or non-verbal distress.
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unfamiliarity with the legal framework. These findings 
again underscore the need for collaborative interdiscipli-
nary practice and research.
Limitations
The recommendations may not be exhaustive of all the 
ethical challenges encountered regarding the three topics. 
This is related to the particular format of a one-day closed 
workshop with the aim of developing best practice guid-
ance among experts in palliative care research, which lim-
ited the number and range of experts who could be invited. 
Therefore, in addition, the workshop needed to focus on 
three topics, which were identified as key to the concerns 
in palliative care research. Only experts from the United 
Kingdom participated in this workshop. For the online 
consultation, a 43% response rate was achieved (26/61) 
following a reminder at 2 weeks. This workshop was the 
fourth workshop in the project, which took place at the 
end of July, and the consultation was open for response in 
the month of August, which is the holiday month for most 
people. This may be an explanation for the relatively low 
response rate. The lay members on the Project Advisory 
Group were not able to attend this workshop, but they 
were involved in all stages before and after the workshop, 
and they were invited to the online consultation.
Conclusion
The results of this workshop and consensus exercise 
provide guidance for ethical issues in palliative care 
research. The culture surrounding palliative care research 
needs to change, which will lead to new ways of thinking 
about research and open up new ways of approaching this 
area. This can best be realised by fostering collaborative 
approaches between those involved in the research process. 
Changes to the legal framework governing the research 
process are required to enhance the ethical conduct of 
research in palliative care. The recommendations are rel-
evant to all areas of research involving vulnerable adults.
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